CHUGAI PHARMACEUTICAL CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,860 JPY | -5.65% |
|
-4.52% | -9.02% |
| 07:18am | Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5% | MT |
| Apr. 24 | Chugai Pharmaceutical's Profit Slightly Up in Q1 | MT |
| Sales 2024 * | 1,092B 7.02B | Sales 2025 * | 1,136B 7.3B | Capitalization | 8,475B 54.47B |
|---|---|---|---|---|---|
| Net income 2024 * | 343B 2.2B | Net income 2025 * | 366B 2.35B | EV / Sales 2024 * | 6.91 x |
| Net cash position 2024 * | 933B 6B | Net cash position 2025 * | 1,003B 6.44B | EV / Sales 2025 * | 6.58 x |
| P/E ratio 2024 * |
24.6
x | P/E ratio 2025 * |
23.1
x | Employees | 7,604 |
| Yield 2024 * |
1.64% | Yield 2025 * |
1.73% | Free-Float | 38.08% |
More Fundamentals
* Assessed data
More news
Latest transcript on Chugai Pharmaceutical Co., Ltd
More recommendations
More press releases
| 1 day | -5.65% | ||
| 1 week | -4.52% | ||
| Current month | -15.83% | ||
| 1 month | -16.92% | ||
| 3 months | -10.91% | ||
| 6 months | +10.25% | ||
| Current year | -9.02% |
1 week
4 830.00
5 376.00
1 month
4 830.005 985.00
Current year
4 830.006 697.00
1 year
3 380.006 697.00
3 years
3 191.006 697.00
5 years
2 290.006 697.00
10 years
853.676 697.00
| Managers | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 61 | 87-03-31 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hisafumi Okabe
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Masayuki Oku
BRD | Director/Board Member | 79 | 15-02-28 |
Motoo Ueno
BRD | Director/Board Member | 66 | 84-03-31 |
James H. Sabry
BRD | Director/Board Member | 65 | 19-02-28 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 6.57% | 15 M€ | +5.53% | ||
| 1.87% | 60 M€ | +13.88% | ||
| 1.59% | 4 M€ | +13.95% | ||
| 1.53% | 67,864 M€ | +13.39% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 4,860 | -5.65% | 3 680 700 |
| 24-04-24 | 5,151 | -0.66% | 3,109,900 |
| 24-04-23 | 5,185 | +0.68% | 2,322,000 |
| 24-04-22 | 5,150 | +4.65% | 2,610,900 |
| 24-04-19 | 4,921 | -3.32% | 3,141,300 |
Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT
More quotes
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
5,151
JPY
Average target price
6,044
JPY
Spread / Average Target
+17.33%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.02% | 54.65B | |
| +25.61% | 660B | |
| +22.53% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +13.51% | 219B | |
| -9.65% | 196B | |
| +6.65% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- 4519 Stock
